Start here
The 60-second version
If you read nothing else
- What it is — homocysteine (Hcy) is a sulfur-containing amino acid your body makes while it recycles methionine. You don't eat it; you make it and clear it constantly.
- Why anyone cares — to clear it, your body needs folate B12 B6 (and sometimes B2 / betaine). A high level is often the first visible sign those are running low, or that methylation is strained.
- The target — most labs call up to ~15 µmol/L "normal," but the risk literature points lower: under 10 is a sensible ceiling and many clinicians aim for ~7–9. But lower isn't better: under 7 is already below optimal, not "even better."
- The honest caveat — lowering homocysteine with B-vitamins reliably moves the number, but large heart-attack trials were mostly negative. The clearer wins are in stroke (in low-folate populations) and brain atrophy / cognition — and only in the right people. It's a useful signal, not a magic dial.
- Two lenses — conventional medicine treats Hcy mainly as a marker (of B12/folate deficiency, kidney function); functional/integrative medicine treats it as a modifiable target worth optimising. Both are in here, clearly labelled.
The machinery
The methylation cycle it sits inside
Homocysteine is a crossroads. From here your body can recycle it back to methionine (the "remethylation" route) or dispose of it down the "transsulfuration" route into glutathione, your master antioxidant. Tap any box to see what it does and which nutrient it needs.
ↆ Click a molecule or enzyme
Interpretation
What's normal, optimal, and dangerous?
Drag the slider (or type your value) to see where a number lands. Risk rises continuously — there's no magic cliff — but these bands are how clinicians talk about it.
The bands, in a table
| Band | µmol/L | How it's usually read |
|---|---|---|
| Low / below optimal | < 7 | Below the optimal window — and lower isn't better. Frankly low levels (hypohomocysteinemia) are uncommon and understudied — usually a marker (over-supplementation, low protein, oxidative stress), not a disease. 5 |
| Optimal | 7–9.9 | The healthy, reassuring range where most well-nourished adults sit; comfortable B-vitamin status. |
| Borderline / high-normal | 10–14.9 | "Normal" on many lab sheets, but where risk signals begin to appear. Worth a look at B-vitamins and lifestyle. 3 |
| Moderate | 15–30 | Clinically elevated (hyperhomocysteinemia). Investigate cause: B12/folate, kidney, thyroid, meds, genetics. 4 |
| Intermediate | 30–100 | Marked. Prompts a proper work-up; rarely just diet. |
| Severe | > 100 | Think inherited disease (homocystinuria / CBS deficiency) or severe B12 deficiency. Needs specialist care. |
Reference ranges vary by lab, age, sex and (importantly) whether the sample was handled correctly — see testing below. Treat any single number as a conversation-starter, not a verdict.
When it's the other way — low homocysteine
Most of this guide is about high homocysteine — that's where nearly all the cardiovascular and cognitive evidence sits. A below-optimal result — roughly under 7 µmol/L — is not the 'lower is better' zone; frankly low levels (hypohomocysteinemia) are uncommon (~0.5–1% of people) and far less studied. Lower is not automatically better.
Read a low number as a marker to look upstream, not a disease in itself. The usual reasons:
- Too little is being made — low protein/methionine intake (mostly from meat, so plant-based eaters are more prone), or over-supplementation with folate and B-vitamins. This is the most common cause of a very low number, and easily fixed.
- It's pulled down the other path — oxidative stress raises demand for glutathione and draws homocysteine into that route, so a low level can flag a stretched antioxidant defence.
- Functional medicine also describes "overmethylation" (low Hcy alongside anxiety or poor sleep) — plausible, but the evidence is weak; treat it as a hypothesis, not a fact.
The scarier associations — idiopathic peripheral neuropathy, and higher mortality in dialysis patients — come from observational data with likely reverse causation (a low value reflecting undernutrition and inflammation, not causing harm). A single slightly-low result with no symptoms usually needs nothing.
Practical
How to actually check your level
It's a simple blood draw — but homocysteine is unusually sensitive to how the sample is handled, so a "high" result is sometimes just a lab artefact.
Before the test
Fast 8–12 hours (water is fine). A protein-heavy meal can nudge homocysteine up for a few hours, and fasting makes repeat tests comparable. Tell whoever orders it about all supplements — B12, folate, a multivitamin or a "methylation" complex can lower the number and mask a deficiency.
The catch: sample handling 5
Red blood cells keep making homocysteine after the draw. If the tube sits warm and isn't spun/chilled within about an hour, you get a falsely high result. If your number is surprisingly elevated with no other clues, a careful redraw (chilled tube, prompt processing) is a reasonable first step before anything else.
Tests worth ordering alongside it
Ideally active B12 (holoTC) — more specific than total B12.
Serum and/or red-cell folate.
Methylmalonic acid — rises specifically in true B12 deficiency, helping separate B12 from folate.
Creatinine / eGFR — reduced clearance is a very common reason Hcy is up.
Hypothyroidism raises homocysteine.
Optional and debated (see below) — more a functional-medicine add-on than a routine test.
Re-testing: if you treat a high level, recheck after about 8–12 weeks. Homocysteine responds to B-vitamins within weeks, so it's a fast feedback loop.
Root causes
Why is mine high?
Elevated homocysteine is a syndrome with many causes, not a diagnosis. Expand each to see the mechanism and what to check. Usually it's one or two of these stacked together.
What the evidence says
What high homocysteine is linked to
This is where honesty matters. Homocysteine is associated with a lot of bad outcomes — but "associated" and "causes" aren't the same, and trials that lowered it had mixed results. Here's the fair version, condition by condition.
Cardiovascular disease & stroke
Observationally, higher homocysteine tracks with more heart disease and stroke. A landmark meta-analysis estimated that a 3 µmol/L lower homocysteine goes with roughly 16% less ischaemic heart disease and 24% less stroke.1 But the big randomised trials that lowered homocysteine with B-vitamins (HOPE-2, NORVIT, SEARCH, VISP) mostly failed to cut heart attacks or cardiac death.6 The clearest positive signal is stroke: a Cochrane review found a small reduction, and China's CSPPT trial (folic acid in a low-folate, un-fortified population) reduced first stroke.7
Take-away: homocysteine is at least partly a marker of B-status and kidney function. It may be genuinely causal for stroke where folate is low, less so for heart attacks. Most cardiology guidelines don't recommend routine screening in the general population.
Cognitive decline, brain atrophy & dementia
This is homocysteine's strongest modern story. In the Oxford VITACOG trial, high-dose B-vitamins (folic acid 0.8 mg, B12 0.5 mg, B6 20 mg) slowed brain shrinkage in people with mild cognitive impairment.8 A follow-up imaging study found the treatment cut atrophy in Alzheimer's-vulnerable regions by up to seven-fold — but almost entirely in people whose baseline homocysteine was above ~11 µmol/L.2
Two big "only-if" conditions: the benefit appeared mainly when omega-3 status was good 9 and when homocysteine was elevated to begin with. So it's less "everyone take B-vitamins for their brain" and more "if homocysteine is high and omega-3 is decent, lowering it may protect the brain."
Fertility & pregnancy
Elevated homocysteine and low folate are linked to neural-tube defects (spina bifida), recurrent early miscarriage, pre-eclampsia and other placental problems.10 This is why preconception folate (typically 400 µg, or higher for higher-risk pregnancies) is standard advice regardless of homocysteine. In women with recurrent loss and MTHFR variants, correcting folate/B12 and lowering homocysteine is a common (if still evolving) strategy.
Note: preconception folate is one of the best-evidenced public-health interventions there is. If you're planning a pregnancy, that decision doesn't wait on a homocysteine result.
Bone, kidney & the rest
Higher homocysteine is associated with more osteoporotic fractures, is both a cause and a consequence of chronic kidney disease, and shows up in analyses of depression, migraine and venous clots. A 2024 umbrella review of the whole literature concluded the associations are broad but the causal evidence is uneven — strong in some areas, weak in others.11
What to do
Lowering it — the toolkit
The good news: homocysteine is one of the most responsive markers there is. Fix the input that's short and it usually falls within weeks. Switch between how each medicine views the same tools.
What both camps agree on
The three workhorses
Folate the biggest lever for most people. B12 essential partner (and the one you must not miss — see warning). B6 feeds the disposal route.
Food first: leafy greens, legumes, eggs, fish, and B12 from animal foods or supplements (essential if vegan).
Fix the root cause, not just the number
Treat low thyroid, support kidney health, review medications (metformin, methotrexate, PPIs), cut smoking and heavy alcohol, and correct genuine B12/folate deficiency at its source (e.g. absorption problems).
How conventional medicine plays it
- Uses homocysteine mainly to diagnose and monitor B12/folate deficiency, not as a routine target.
- Ordinary folic acid is considered effective and cheap; for most people it works fine.
- Does not generally recommend B-vitamins to prevent heart attacks, because the big trials were negative.
- Skeptical of routine MTHFR testing — the ACMG advises against it for thrombophilia work-ups.12
- Reserves aggressive treatment for clear deficiency, kidney disease, pregnancy planning, or inherited homocystinuria.
How functional / integrative medicine plays it
- Treats homocysteine as a modifiable methylation marker and aims lower (often <7–8).
- Prefers active forms: methylfolate (5-MTHF) over folic acid, methyl-/adenosyl-B12, P5P (active B6) — reasoning that they bypass activation steps, which matters most for MTHFR C677T "TT" carriers.13
- Adds riboflavin (B2) for C677T carriers — it's the MTHFR cofactor and lowers Hcy specifically in that genotype.
- Uses betaine (TMG) ~1.5–3 g and/or choline when B-vitamins alone don't finish the job (they power the backup BHMT route).
- Pairs with omega-3, given the brain-atrophy interaction, and looks upstream at gut absorption, stress and diet.
Fair critique: the head-to-head evidence that methylfolate beats folic acid is modest outside TT carriers, active forms cost more, and "optimising" a marker isn't the same as proven outcomes. The upside is that the interventions are cheap and low-risk when B12 is covered.
Not a single point of view
The two lenses, side by side
You asked for more than one perspective. Here's the same marker seen two ways — both are defensible; the truth is that they're answering slightly different questions.
🩺 Conventional / evidence-based
- Question it answers: "Does treating this number change hard outcomes in trials?"
- Homocysteine ≈ a marker of B12/folate status and kidney function.
- Lowering it pharmacologically didn't reduce heart attacks → don't screen everyone.
- Order it for a reason: deficiency, young/unexplained stroke or clot, cognitive concern, pregnancy loss, suspected homocystinuria.
- Strength: rigorous, trial-anchored. Blind spot: can under-value cheap, safe prevention and subgroup wins.
🌿 Functional / integrative
- Question it answers: "Is this system strained, and can I optimise it safely?"
- Homocysteine ≈ a modifiable target and a window on methylation.
- Acts on the stroke & brain-atrophy signals and the low cost/risk of correcting it.
- Personalises with genetics, active vitamers, cofactors and diet; aims lower.
- Strength: proactive, root-cause, cheap. Blind spot: can over-interpret a marker and over-supplement.
The severe end
Homocystinuria — when it's a disease, not a marker
At the extreme sits classical homocystinuria, an inherited deficiency of the CBS enzyme (the B6-dependent disposal gate). Homocysteine runs very high (often >100 µmol/L). Untreated, it causes a dislocated eye lens, a tall Marfan-like build, developmental problems and — most dangerously — blood clots, the leading cause of death; historical series report an 18% mortality by age 30.14 Many countries screen newborns for it. Treatment includes high-dose vitamin B6 (some cases are "B6-responsive"), betaine, a low-methionine diet, and folate/B12.
Why include it? Because it's the proof-of-concept that homocysteine can be directly harmful at high enough levels — which is part of why the milder elevations are taken seriously.
Plain definitions
Glossary
- Homocysteine (Hcy)
- A sulfur amino acid made while recycling methionine; your blood level reflects B-vitamin status and methylation.
- Methylation
- Attaching a –CH₃ (methyl) group to DNA, proteins, neurotransmitters and more. Runs the body's "labelling" system.
- Remethylation
- Recycling homocysteine back into methionine, using folate + B12 (or betaine).
- Transsulfuration
- Disposing of homocysteine down into cysteine and glutathione, using vitamin B6.
- SAM / SAH
- S-adenosylmethionine (the universal methyl donor) and its spent form. Their ratio measures methylation capacity.
- 5-MTHF (methylfolate)
- The active, usable form of folate that donates the methyl group in remethylation.
- MTHFR
- The enzyme that makes 5-MTHF. Common variants (C677T, A1298C) can slow it; the "TT" genotype raises homocysteine most.
- MMA
- Methylmalonic acid — a second marker that rises specifically in true B12 deficiency.
- Betaine (TMG)
- Trimethylglycine; fuels the backup homocysteine→methionine route in liver and kidney.
- Hyperhomocysteinemia
- The medical term for an elevated homocysteine level (classically >15 µmol/L).
Keep reading — it's free
You've got the part that shows you where you stand. The rest is what to actually do about it — and I'll send it straight to your screen.
Still to come in this guide:
- What high homocysteine is linked to
- Lowering it — the toolkit
- The two lenses, side by side
- Homocystinuria — when it's a disease, not a marker
- Glossary
No charge, ever. Just my guides and the occasional new one. Unsubscribe any time.
Go deeper
Key papers & further reading
Primary sources behind the claims above, grouped so you can build real literacy. Superscript numbers in the text map to these.
Biochemistry & the cycle
Levels, risk & the "marker vs cause" debate
The B-vitamin trials
Genetics, pregnancy & the severe end